相关实验视频

Updated: Jul 24, 2025

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

毒素在帕金森症疾病的管理中

Talyta Grippe¹, Robert Chen²

¹Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada; Division of Neurology, University of Toronto, Toronto, Ontario, Canada; Neuroscience Graduate Program, Federal University of Minas Gerais, Belo Horizonte, Brazil; Krembil Brain Institute, Toronto, Ontario, Canada; Divison of Neurology, Department of Medicine, University of Toronto, Canada.

Toxicon : official journal of the International Society on Toxinology

|July 10, 2023

概括

毒素 (BoNT) 提供局部治疗帕金森病 (PD) 症状,如震和. 虽然有望改善生活质量,但需要更多高质量的研究来证实疗效和最佳使用.

科学领域:

神经学神经学
药理学药理学是指药理学的学科.

背景情况:

帕金森病 (PD) 呈现出各种运动和非运动症状.
由于其局部作用和最小的全身副作用,毒素 (BoNT) 正被探索为一种治疗选择.
目前关于PD中BoNT的证据主要来自开放标签研究.

研究的目的:

审查当前用于治疗帕金森病 (PD) 和相关综合征的运动和非运动症状的肉毒毒素 (BoNT) 的应用.
评估现有证据基础,突出强烈支持的领域和需要进一步调查的领域.
强调BoNT在改善患者生活质量的潜力.

主要方法:

对研究毒素 (BoNT) 治疗帕金森病 (PD) 症状的文献综述.
对各种运动症状 (如 dystonia,震) 和非运动症状 (如 sialorrhea,疼痛) 报告的疗效的分析.
证据质量的评估,区分开放标签研究和随机对照试验.

主要成果:

毒素 (BoNT) 有效治疗特定的运动症状,包括白发作,宫 dystonia 和四肢 dystonia.
对于非运动性症状,如腹,疼痛,消化不良和便秘等,有潜在的益处.
对于行走结和运动障碍等症状的证据不那么强大.
大多数研究是开放的,随机对照试验很少.

结论:

毒素 (BoNT) 是一种有价值的工具,用于管理帕金森病 (PD) 中选择的运动和非运动症状,提高患者的生活质量.
支持许多当前应用的高质量证据有限.
进一步的随机对照试验对于确定最终的疗效和优化治疗方案至关重要,包括剂量和肌肉选择.

关键词:

血发 (Blepharospasm) 是一种发的情况.肉毒毒素是一种毒素.疼痛疼痛疼痛疼痛帕金森症帕金森症这种病名为Sialorrhea.震动是一种震动.

更多相关视频

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...